Evidence map›Paper›PMID 34516250›Full record

ArticleAntimicrobial agents and chemotherapy2021

Lactococcus lactis Resistance to Aureocin A53- and Enterocin L50-Like Bacteriocins and Membrane-Targeting Peptide Antibiotics Relies on the YsaCB-KinG-LlrG Four-Component System.

Aleksandra Tymoszewska, Kirill V Ovchinnikov, Dzung B Diep, Małgorzata Słodownik, Edyta Maron, Beatriz Martínez, Tamara Aleksandrzak-Piekarczyk

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. Design of Novel Saposin-like Bacteriocins Using a Hybrid Approach.Probiotics and antimicrobial proteins · 2025
    Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Aleksandra TymoszewskaInstitute of Biochemistry and Biophysics, Polish Academy of Sciences (IBB PAS), Warsaw, Poland.ORCID 0000-0002-7848-0679
Kirill V OvchinnikovFaculty of Chemistry, Biotechnology, and Food Science, Norwegian University of Life Sciencesgrid.19477.3c, Ås, Norway.ORCID 0000-0002-4767-8666
Dzung B DiepFaculty of Chemistry, Biotechnology, and Food Science, Norwegian University of Life Sciencesgrid.19477.3c, Ås, Norway.ORCID 0000-0001-7661-5501
Małgorzata SłodownikInstitute of Biochemistry and Biophysics, Polish Academy of Sciences (IBB PAS), Warsaw, Poland.
Edyta MaronInstitute of Biochemistry and Biophysics, Polish Academy of Sciences (IBB PAS), Warsaw, Poland.
Beatriz MartínezDepartment of Technology and Biotechnology of Dairy Products, Instituto de Productos Lácteos de Asturias, Consejo Superior de Investigaciones Científicas (IPLA-CSIC), Villaviciosa, Spain.ORCID 0000-0001-7692-1963
Tamara Aleksandrzak-PiekarczykInstitute of Biochemistry and Biophysics, Polish Academy of Sciences (IBB PAS), Warsaw, Poland.ORCID 0000-0002-4725-760X
Institute of Biochemistry and Biophysics, Polish Academy of Sciences · PLNorwegian University of Life Sciences · NOConsejo Superior de Investigaciones Científicas · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Resistance to nonribosomally synthesized peptide antibiotics affecting the cell envelope is well studied and mostly associated with the action of peptide-sensing and detoxification (PSD) modules, which consist of a two-component system (TCS) and an ATP-binding cassette (ABC) transporter. In contrast, the mechanisms of resistance to ribosomally synthesized bacterial toxic peptides (bacteriocins), which also affect the cell envelope, are studied to a lesser extent, and the possible cross-resistance between them and antibiotics is still poorly understood. In the present study, we investigated the development of resistance of Lactococcus lactis to aureocin A53- and enterocin L50-like bacteriocins and cross-resistance with antibiotics. First, 19 spontaneous mutants resistant to their representatives were selected and also displayed changes in sensitivity to peptide antibiotics acting on the cell envelope (bacitracin, daptomycin, and gramicidin). Sequencing of their genomes revealed mutations in genes encoding the ABC transporter YsaCB and the TCS KinG-LlrG, the emergence of which induced the upregulation of the

Indexed as

BacteriocinsLactococcus lactisAnti-Bacterial AgentsBridged-Ring CompoundsDrug Resistance, BacterialPeptidesAnti-Bacterial AgentsBacteriocinsBridged-Ring CompoundsenterocinPeptidesantibiotic resistanceaureocin A53-like and enterocin L50-like bacteriocinsbacitracinbacitracin transporterbacteriocin resistanceclass II leaderless bacteriocinsdaptomycingramicidinpeptide antibioticstwo-component system

Identifiers

PMID34516250
PMCPMC8597747
OpenAlexW3199147170

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.